Compare CCC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCC | SRRK |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.6B |
| IPO Year | N/A | 2018 |
| Metric | CCC | SRRK |
|---|---|---|
| Price | $8.07 | $45.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $8.00 | ★ $47.88 |
| AVG Volume (30 Days) | ★ 7.0M | 1.4M |
| Earning Date | 10-30-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,025,600,000.00 | N/A |
| Revenue This Year | $12.72 | N/A |
| Revenue Next Year | $9.30 | $20,271.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.64 | N/A |
| 52 Week Low | $6.96 | $22.71 |
| 52 Week High | $11.96 | $48.28 |
| Indicator | CCC | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 61.71 |
| Support Level | N/A | $42.61 |
| Resistance Level | N/A | $46.38 |
| Average True Range (ATR) | 0.00 | 1.88 |
| MACD | 0.00 | -0.34 |
| Stochastic Oscillator | 0.00 | 56.72 |
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.